Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nephros Inc (NEPH)
NASDAQ:NEPH
Holding NEPH?
Track your performance easily
Earnings Data
Report Date
Feb 26, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
-$0.02Last Year’s EPS
-$0.06Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 07, 2024
|% Change Since: -4.52%
|Next Earnings Date:Feb 26, 2025
Earnings Call Sentiment|Neutral
While Nephros achieved its first profitable quarter and improved its gross margin and adjusted EBITDA, the company faced a decline in year-over-year revenue and cash reserves, along with regional underperformance challenges. Despite these issues, strategic initiatives and cost management have positioned Nephros for potential future growth.Company Guidance
During the Nephros Q3 2024 earnings call, the company reported achieving its first profitable quarter since inception, with a net income of $0.2 million compared to a net loss of $0.2 million in Q3 2023. Net revenue for the quarter was $3.5 million, up 8% from Q2 2024 but down 6% from Q3 2023. The gross margin improved to 61% from 59% in Q3 2023, driven by better terms with a major supplier. Adjusted EBITDA for the quarter was $295,000, a significant improvement from $11,000 in the previous year. SG&A expenses were reduced by 19% to $1.7 million, contributing to the positive financial outcome. The company highlighted strategic advancements, such as the introduction of digital support tools for filter installation and plans to expand into new markets like sterile processing and dental practices. Cash and cash equivalents stood at $2.5 million as of September 30, 2024, down from $4.3 million at the end of 2023, primarily due to earlier operating losses and inventory investments.First Profitable Quarter Achieved
Nephros reported its first profitable quarter with a net income of $0.2 million compared to a net loss of $0.2 million in Q3 of the previous year.
Improved Gross Margin
Gross margin increased to 61% from 59% in Q3 2023, reflecting improved terms with the largest supplier.
Significant Improvement in Adjusted EBITDA
Adjusted EBITDA for Q3 was $295,000, a substantial increase from $11,000 in the same quarter last year.
SG&A Expenses Reduction
SG&A expenses were reduced by 19% to $1.7 million from $2.1 million in Q3 2023 due to lower stock compensation and bonus accruals.
Strategic Advancements and Future Growth
Nephros is expanding into new markets such as sterile processing, laboratories, and dental practices and is exploring partnerships for solutions to nano and microplastic contaminations.
---
NEPH Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
NEPH Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 07, 2024 | $1.55 | $1.61 | +3.87% |
| Aug 08, 2024 | $2.14 | $1.96 | -8.41% |
| May 09, 2024 | $2.22 | $2.10 | -5.41% |
| Mar 07, 2024 | $3.02 | $2.70 | -10.60% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Nephros Inc (NEPH) report earnings?
Nephros Inc (NEPH) is schdueled to report earning on Feb 26, 2025, TBA Not Confirmed.
What is Nephros Inc (NEPH) earnings time?
Nephros Inc (NEPH) earnings time is at Feb 26, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is NEPH EPS forecast?
NEPH EPS forecast for the fiscal quarter 2024 (Q4) is -$0.02.
---